CF
MRNA icon

Centaurus Financial’s Moderna MRNA Stock Holding History

Centaurus Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Sell
4,477
-5,700
-56% -$266K 0.01% 779
2025
Q4 		$300K Sell
10,177
-6,007
-37% -$163K 0.01% 683
2025
Q3 		$418K Buy
16,184
+10,007
+162% +$279K 0.02% 574
2025
Q2 		$170K Sell
6,177
-35
-0.6% -$922 0.01% 776
2025
Q1 		$176K Sell
6,212
-75
-1% -$2.66K 0.01% 716
2024
Q4 		$261K Sell
6,287
-13
-0.2% -$621 0.02% 592
2024
Q3 		$421K Sell
6,300
-35
-0.6% -$3.21K 0.03% 447
2024
Q2 		$752K Sell
6,335
-608
-9% -$76.9K 0.05% 295
2024
Q1 		$740K Sell
6,943
-140
-2% -$14.1K 0.05% 295
2023
Q4 		$704K Buy
7,083
+214
+3% +$18K 0.05% 299
2023
Q3 		$709K Sell
6,869
-68
-1% -$7.58K 0.06% 293
2023
Q2 		$843K Sell
6,937
-1,555
-18% -$207K 0.07% 266
2023
Q1 		$1.3M Buy
8,492
+35
+0.4% +$5.77K 0.1% 219
2022
Q4 		$1.52M Sell
8,457
-403
-5% -$65.9K 0.14% 174
2022
Q3 		$1.05M Sell
8,860
-110
-1% -$16.7K 0.1% 231
2022
Q2 		$1.28M Sell
8,970
-374
-4% -$53.5K 0.13% 195
2022
Q1 		$1.61M Buy
9,344
+39
+0.4% +$6.57K 0.13% 193
2021
Q4 		$2.36M Sell
9,305
-606
-6% -$177K 0.18% 151
2021
Q3 		$3.81M Sell
9,911
-3,445
-26% -$1.27M 0.32% 72
2021
Q2 		$3.14M Buy
13,356
+6,918
+107% +$1.24M 0.26% 92
2021
Q1 		$843K Buy
6,438
+1,198
+23% +$174K 0.08% 265
2020
Q4 		$547K Sell
5,240
-3,923
-43% -$397K 0.06% 338
2020
Q3 		$648K Buy
9,163
+537
+6% +$37.4K 0.09% 238
2020
Q2 		$554K Buy
8,626
+5,126
+146% +$281K 0.08% 264
2020
Q1 		$105K Buy
+3,500
New +$80.5K 0.02% 480

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centaurus Financial's MRNA Position: Q1 2026 in Review

Centaurus Financial reduced its Moderna (MRNA) stake by 56% in Q1 2026, selling an estimated $266K and leaving 4,477 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #779.

Centaurus Financial first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.81M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Centaurus Financial held 4,477 shares of Moderna worth $227K as of Q1 2026.
  • Centaurus Financial sold 5,700 Moderna shares in Q1 2026, an estimated $266K.
  • Moderna made up 0.01% of Centaurus Financial's portfolio in Q1 2026, its #779 holding.
  • Centaurus Financial first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
  • Centaurus Financial's Moderna position peaked at $3.81M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.